Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Matthew Herper covers medical innovation — both its promise and its perils. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

The clinical trial tech companies Medidata and Medable are both taking to the floor of the American Society of Clinical Oncology meeting in Chicago to spread the word about new offerings. Medidata’s ...

The first half of this year has been riddled with market volatility and geopolitical tension. But 2025’s American Society of Clinical Oncology conference largely isn’t reflecting that turmoil. In fact ...

In the 1970s and ‘80s, traces of the artist collective Asco, named after the Spanish word for “disgust,” could be seen all over East L.A. The then-teenage creatives pulled all kinds of high jinks in ...

This story has been updated with expert comments. The American Society of Clinical Oncology (ASCO) and Google Cloud have recently launched an artificial intelligence (AI)–powered search tool to ...

Pfizer isn’t stopping to smell the roses on its speed run to secure a full FDA approval for its Braftovi combination therapy. After securing a unique accelerated approval not quite six months ago, the ...

Heather McArthur, MD, describes how the 2025 ASCO Annual Meeting brought exciting advances in the metastatic breast cancer space. In PD-L1-positive triple-negative breast cancer, sacituzumab govitecan ...

There's a Touch-a-Truck this weekend to raise money for Unbound Now, an organization dedicated to supporting and empowering ...